Factors Affecting Psoas Muscle Mass Index in Patients Undergoing Peritoneal Dialysis.

computed tomography peritoneal dialysis psoas muscle mass index sarcopenia serum albumin concentration vitamin d

Journal

Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737

Informations de publication

Date de publication:
Mar 2024
Historique:
accepted: 17 03 2024
medline: 18 4 2024
pubmed: 18 4 2024
entrez: 18 4 2024
Statut: epublish

Résumé

Many patients with chronic kidney disease (CKD), including peritoneal dialysis (PD), have sarcopenia. It is important to evaluate muscle mass to prevent sarcopenia in the field of CKD management. Recently, muscle mass assessment using psoas muscle evaluated by computed tomography (CT) has been reported in patients undergoing hemodialysis. However, few clinical studies have investigated the clinical factors associated with the evaluation of psoas muscle in patients undergoing PD. Psoas muscle mass index (PMI) was measured in cross-sectional areas of the bilateral psoas muscles at the third lumbar spine level to evaluate psoas muscle status. The associations between PMI and possible clinical factors were investigated in 68 patients undergoing PD. The mean PMI was 6.3 ± 2.0 cm PMI was independently and significantly associated with gender, BMI, serum creatinine concentration, serum albumin concentration and the use of vitamin D. Further prospective studies are needed to clarify whether the maintenance of nutritional status or vitamin D administration could affect muscle mass in patients undergoing PD.

Identifiants

pubmed: 38633934
doi: 10.7759/cureus.56347
pmc: PMC11021792
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e56347

Informations de copyright

Copyright © 2024, Hirata et al.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Auteurs

Momoko Hirata (M)

First Department of Integrated Medicine, Saitama Medical Center, Jichi Medical University, Saitama, JPN.

Kiyonori Ito (K)

First Department of Integrated Medicine, Saitama Medical Center, Jichi Medical University, Saitama, JPN.

Susumu Ookawara (S)

First Department of Integrated Medicine, Saitama Medical Center, Jichi Medical University, Saitama, JPN.

Keisuke Tanno (K)

First Department of Integrated Medicine, Saitama Medical Center, Jichi Medical University, Saitama, JPN.

Junki Morino (J)

First Department of Integrated Medicine, Saitama Medical Center, Jichi Medical University, Saitama, JPN.

Saori Minato (S)

First Department of Integrated Medicine, Saitama Medical Center, Jichi Medical University, Saitama, JPN.

Yuko Mutsuyoshi (Y)

First Department of Integrated Medicine, Saitama Medical Center, Jichi Medical University, Saitama, JPN.

Taisuke Kitano (T)

First Department of Integrated Medicine, Saitama Medical Center, Jichi Medical University, Saitama, JPN.

Keiji Hirai (K)

First Department of Integrated Medicine, Saitama Medical Center, Jichi Medical University, Saitama, JPN.

Yoshiyuki Morishita (Y)

First Department of Integrated Medicine, Saitama Medical Center, Jichi Medical University, Saitama, JPN.

Classifications MeSH